Cubist Systematic Strategies, LLC - G1 THERAPEUTICS INC ownership

G1 THERAPEUTICS INC's ticker is GTHX and the CUSIP is 3621LQ109. A total of 102 filers reported holding G1 THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is 0.54 and the average weighting 0.1%.

Quarter-by-quarter ownership
Cubist Systematic Strategies, LLC ownership history of G1 THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$30,757
-92.6%
21,359
-86.2%
0.00%
-100.0%
Q1 2023$413,433
+3.8%
154,266
+110.4%
0.00%
+50.0%
Q4 2022$398,187
-92.8%
73,331
-83.5%
0.00%
-93.5%
Q3 2022$5,556,000
+336.1%
444,841
+72.5%
0.03%
+287.5%
Q2 2022$1,274,000
+24.5%
257,912
+91.7%
0.01%
-11.1%
Q1 2022$1,023,000
+176.5%
134,566
+388.3%
0.01%
+80.0%
Q3 2021$370,000
+210.9%
27,560
+409.5%
0.01%
+400.0%
Q2 2021$119,000
-56.7%
5,409
-52.7%
0.00%
-75.0%
Q1 2021$275,000
+49.5%
11,438
+12.0%
0.00%
+33.3%
Q4 2020$184,000
+28.7%
10,212
-17.3%
0.00%
+50.0%
Q3 2020$143,000
+1942.9%
12,343
+4437.9%
0.00%
Q2 2020$7,000
-97.6%
272
-99.0%
0.00%
-100.0%
Q1 2020$296,000
-4.8%
26,896
+128.5%
0.01%
+33.3%
Q4 2019$311,000
+13.5%
11,769
+31.6%
0.01%
+20.0%
Q2 2019$274,000
-57.8%
8,945
-77.1%
0.01%
-76.2%
Q1 2019$649,000
+31.4%
39,086
+51.6%
0.02%
-8.7%
Q4 2018$494,000
+79.0%
25,781
+388.5%
0.02%
+53.3%
Q3 2018$276,000
+165.4%
5,278
+88.9%
0.02%
+150.0%
Q1 2018$104,000
+1055.6%
2,794
+484.5%
0.01%
Q4 2017$9,0004780.00%
Other shareholders
G1 THERAPEUTICS INC shareholders Q3 2022
NameSharesValueWeighting ↓
MPM BioImpact LLC 1,423,794$34,541,0009.18%
Burrage Capital Management LLC 373,876$9,070,0006.35%
Birchview Capital, LP 40,000$970,0000.59%
361 CAPITAL LLC 47,325$1,148,0000.54%
Rhenman & Partners Asset Management AB 190,000$4,609,0000.50%
CHI Advisors LLC 44,000$1,067,0000.42%
Bellevue Group AG 721,925$17,514,0000.25%
Candriam S.C.A. 870,423$21,117,0000.22%
Virtus ETF Advisers LLC 18,991$461,0000.22%
HHLR ADVISORS, LTD. 949,431$23,033,0000.21%
View complete list of G1 THERAPEUTICS INC shareholders